Scinai Immunotherapeutics Ltd. Recorded Big Gain
Mon, Sep 14, 2026 at 07:42 PM
Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ) shot up at $2.44, representing a gain of 47%. On Mon, Sep 14, 2026, SCNI:NASDAQ touched a New 2-Week Intraday High of $2.67. The stock got featured on our News Catalysts scanner on Tue, Sep 08, 2026 at 11:34 AM in the 'AGREEMENT' category. From Mon, Aug 31, 2026, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Fri, Apr 24, 2026 at $10.5 with a volume of 20M+.
About Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ)
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine.
Top 10 Gainers:
- Vestand Inc Cl A (New) (VSTD:NASDAQ), 333.33%
- Future FinTech Group Inc. (FTFT:NASDAQ), 179.17%
- Intercont (Cayman) Limited (NCT:NASDAQ), 66.83%
- Basel Medical Group Ltd (BMGL:NASDAQ), 55.21%
- Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ), 46.99%
- Veea Inc. (VEEA:NASDAQ), 46.79%
- Vince Holding Corp. (VNCE:NASDAQ), 45.99%
- Vince Holding Corp. (VNCE:NYSE), 45.99%
- PDS Biotechnology Corporation (PDSB:NASDAQ), 35.33%
- The Elmet Group Co. (ELMT:NASDAQ), 32.8%